These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22162713)

  • 1. HLA class II defects in Burkitt lymphoma: bryostatin-1-induced 17 kDa protein restores CD4+ T-cell recognition.
    Hossain A; God JM; Radwan FF; Amria S; Zhao D; Bethard JR; Haque A
    Clin Dev Immunol; 2011; 2011():780839. PubMed ID: 22162713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition.
    God JM; Zhao D; Cameron CA; Amria S; Bethard JR; Haque A
    Immunology; 2014 Jul; 142(3):492-505. PubMed ID: 24628049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of HLA class II-restricted CD4+ T cell recognition of human melanoma cells following treatment with bryostatin-1.
    Zhao D; Amria S; Hossain A; Sundaram K; Komlosi P; Nagarkatti M; Haque A
    Cell Immunol; 2011; 271(2):392-400. PubMed ID: 21903207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumors.
    God JM; Cameron C; Figueroa J; Amria S; Hossain A; Kempkes B; Bornkamm GW; Stuart RK; Blum JS; Haque A
    J Immunol; 2015 Feb; 194(4):1434-45. PubMed ID: 25595783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms regulating enhanced human leukocyte antigen class II-mediated CD4 + T cell recognition of human B-cell lymphoma by resveratrol.
    Radwan FF; Zhang L; Hossain A; Doonan BP; God JM; Haque A
    Leuk Lymphoma; 2012 Feb; 53(2):305-14. PubMed ID: 21854084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLs.
    Khanna R; Burrows SR; Thomson SA; Moss DJ; Cresswell P; Poulsen LM; Cooper L
    J Immunol; 1997 Apr; 158(8):3619-25. PubMed ID: 9103423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma.
    Rousset F; Malefijt RW; Slierendregt B; Aubry JP; Bonnefoy JY; Defrance T; Banchereau J; de Vries JE
    J Immunol; 1988 Apr; 140(8):2625-32. PubMed ID: 2965726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock protein 90-mediated peptide-selective presentation of cytosolic tumor antigen for direct recognition of tumors by CD4(+) T cells.
    Tsuji T; Matsuzaki J; Caballero OL; Jungbluth AA; Ritter G; Odunsi K; Old LJ; Gnjatic S
    J Immunol; 2012 Apr; 188(8):3851-8. PubMed ID: 22427632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous HLA class II epitopes that are immunogenic in vivo show distinct behavior toward HLA-DM and its natural inhibitor HLA-DO.
    Kremer AN; van der Meijden ED; Honders MW; Goeman JJ; Wiertz EJ; Falkenburg JH; Griffioen M
    Blood; 2012 Oct; 120(16):3246-55. PubMed ID: 22889757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melan-A/MART-1-specific CD4 T cells in melanoma patients: identification of new epitopes and ex vivo visualization of specific T cells by MHC class II tetramers.
    Bioley G; Jandus C; Tuyaerts S; Rimoldi D; Kwok WW; Speiser DE; Tiercy JM; Thielemans K; Cerottini JC; Romero P
    J Immunol; 2006 Nov; 177(10):6769-79. PubMed ID: 17082590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma.
    Goldstein OG; Hajiaghamohseni LM; Amria S; Sundaram K; Reddy SV; Haque A
    Cancer Immunol Immunother; 2008 Oct; 57(10):1461-70. PubMed ID: 18343923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In cutaneous T-cell lymphoma, class II MHC molecules on CD1+ antigen-presenting cells are upregulated in involved compared with uninvolved epidermis.
    Hansen ER; Bang B; Larsen JK; Vejlsgaard GL; Baadsgaard O
    Br J Dermatol; 1994 Dec; 131(6):780-8. PubMed ID: 7531998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of HLA class-I antigens in Burkitt lymphoma cells.
    Andersson ML; Stam NJ; Klein G; Ploegh HL; Masucci MG
    Int J Cancer; 1991 Feb; 47(4):544-50. PubMed ID: 1899854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition.
    Griffin H; Rowe M; Murray R; Brooks J; Rickinson A
    Eur J Immunol; 1992 Jul; 22(7):1741-8. PubMed ID: 1378014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
    Machy P; Serre K; Baillet M; Leserman L
    J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
    Masucci MG; Torsteindottir S; Colombani J; Brautbar C; Klein E; Klein G
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4567-71. PubMed ID: 3037521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of HLA expression as a possible factor in the pathogenesis of Burkitt's lymphoma.
    Voltz R; Jilg W; Wolf H
    Haematol Blood Transfus; 1989; 32():289-92. PubMed ID: 2560446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class II molecules regulate growth in human T cells.
    Nielsen M; Odum N; Bendtzen K; Ryder LP; Jakobsen BK; Svejgaard A
    Exp Clin Immunogenet; 1994; 11(1):23-32. PubMed ID: 7913331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment with interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha up-regulates the expression of HLA class I determinants in Burkitt lymphoma lines.
    Avila-Carino J; Torsteinsdottir S; Bejarano MT; Klein G; Klein E; Masucci MG
    Cell Immunol; 1988 Dec; 117(2):303-11. PubMed ID: 2848629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.